• Markets
• News
• Learn

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Canaccord Genuity analyst Carey MacRury initiated coverage on Gold Royalty Corp. (AMEX:GROY) with a Buy rating and announced a price target of $3. Gold Royalty shares closed at $1.97 on Tuesday. See how other analysts view this stock.
• Jefferies analyst Dennis Ding initiated coverage on Mineralys Therapeutics, Inc. (NASDAQ:MLYS) with a Hold rating and announced a price target of $15. Mineralys Therapeutics shares closed at $16.03 on Tuesday. See how other analysts view this stock.
• Leerink Partners analyst Daina Graybosch initiated coverage on Summit Therapeutics Inc. (NASDAQ:SMMT) with an Underperform rating and announced a price target of $12. Summit Therapeutics shares closed at $22.08 on Tuesday. See how other analysts view this stock.
• UBS analyst Myles Allsop initiated coverage on Core Natural Resources, Inc. (NYSE:CNR) with a Buy rating and announced a price target of $80. Core Natural Resources shares closed at $67.38 on Tuesday. See how other analysts view this stock.
• William Blair analyst Andrew Jeffrey initiated coverage on Coinbase Global, Inc. (NASDAQ:COIN) with an Outperform rating. Coinbase shares closed at $254.94 on Tuesday. See how other analysts view this stock.

Considering buying COIN stock? Here’s what analysts think:

Read This Next:

• Top 2 Tech And Telecom Stocks You May Want To Dump In Q2

Photo via Shutterstock